期刊文献+

高效液相色谱串联质谱法测定人体血浆中阿那曲唑的浓度 被引量:1

Determination of anastrozole in human plasma by HPLC-MS/MS
下载PDF
导出
摘要 目的建立液质联用法来检测人体血浆中阿那曲唑的浓度。方法血浆样品经MTBE萃取后,选用来曲唑为内标。色谱柱为Thermo Hypurity C18柱(2.1 mm×150 mm,5μm);流动相为乙腈-0.1%甲酸(60∶40);流速为0.20 mL.min-1;采用ESI+MRM进行离子方式监测;源电压:3.6 kV;源温度:100℃;阿那曲唑和来曲唑的离子选择通道分别为:m/z294.69→225.41,286.25→217.60。结果阿那曲唑的线性范围为0.214~214 ng.mL-1,最低检测浓度为0.214 ng.mL-1,方法回收率在80%~120%,日内、日间RSD均〈15%。结论本方法简单、灵敏,可以准确检测人体血浆中阿那曲唑的浓度。 Objective To establish an HPLC-MS/MS method for the determination of anastrozole in human plasma.Methods Plasma sample was extracted by MTBE and letrozol was chosen as the internal standard.The separation was performed on a Thermo Hypurity C18(2.1 mm×150 mm,5 μm) column.The mobile phase was acetonitrile-0.1% formic acid(60∶40,v/v) at 0.20 mL·min-1.The analytes were detected by the electronic-spray ionization(ESI)-multiple reaction monitoring(MRM) mode.MS detection parameters:the source voltage was 3.6 kV and the source temperature was 100 ℃.Anastrozole and letrozol ion selective channels were: m/z294.69→225.41,286.25→217.60.Results The linear range for anastrozole was 0.214-214 ng·mL-1 and the minimum detectable concentration was 0.214 ng·mL-1.The mean relative recovery was 80%-120% and the relative standard deviation of intra-day and inter-day was less than 15%.Conclusion This method is simple and sensitive,which can be used to determinate the concentration of anastrozole in human plasma.
出处 《中南药学》 CAS 2011年第6期437-440,共4页 Central South Pharmacy
关键词 HPLC-MS/MS 阿那曲唑 药物动力学 HPLC-MS/MS anastrozole pharmacokinetics
  • 相关文献

参考文献12

二级参考文献17

  • 1朱林,陈笑艳,钟大放.液相色谱-质谱法测定人体血浆中阿那曲唑[J].质谱学报,2003,24(z1):103-104. 被引量:5
  • 2曾衍霖.对《新药生物等效度》申报材料写作的规范化建议[J].中国临床药理学杂志,1995,11(1):58-62. 被引量:9
  • 3杨静华.乳腺癌治疗药——芳香酶抑制剂类研究进展[J].中国新药杂志,1995,4(2):6-11. 被引量:6
  • 4.中国药典:1995年版二部[S].,1995.附录ⅣA.
  • 5[1]Bock MJH, Bara I, LeDonne N, Martz A, Dyroff M. Validated assay for the quantification of anastrozole in human plasma by capillary gas chromatography-63Ni electron capture detection[J]. J Chromatogr B, 1997, 700: 131-138.
  • 6[2]Demers M. Effects of Fadrozole (CGS 16949A) and letrozole (CGS 20267) on the inhibition of aromatase activity in breast cnacer patients[J]. Breast Cancer Res Treat, 1994, 30:95-102.
  • 7[3]Geisler J, King N, Dowserr M, et al. Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer[J]. Br J Cancer, 1996, 74:1286-1291.
  • 8[1]Gengli,Duan, Jianying Liang, et al. Rapid Determination of Anastrozole in Plasma by Gas Chromatography With Electron Capture Detection and its Application to an Oral Pharmacokinetic Study in Healthy Volunteers [J]. Biomed Chromatogr,2002 ,16(6) :400~403.
  • 9[2]Geisler J, Berntsen H, Lonning PE. A Novel HPLC-RIA Method for the Simultaneous Detection of Estrone, Estradiol and Estrone Sulphate Levels in Breast Cancer Tissue [J]. J Steroid Biochem Mol Biol,2000 , 72(5):259~264.
  • 10[3]Bock MJ, Bara I, Ledonne N, et al. Validated Assay for the Quantification of Anastrozole in Human Plasma by Capillary Gas Chromatography-63Ni Electron Capture Detection[J]. J Chromatogr B Biomed Sci Appl, 1997 ,700(1~2):131~138.

共引文献17

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部